US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Telix Pharmaceuticals Ltd. (Uplisting)

10.55

-0.1700-1.59%

Post-market: 10.840.2914+2.76%19:30 EDT

Volume:299.61K

Turnover:3.16M

Market Cap:3.58B

PE:110.60

High:10.64

Open:10.64

Low:10.45

Close:10.72

52wk High:13.11

52wk Low:6.28

Shares:339.00M

Float Shares:272.00M

Volume Ratio:0.67

T/O Rate:0.11%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.0954

EPS(LYR):-0.0211

ROE:7.36%

ROA:2.71%

PB:7.33

PE(LYR):-500.00

Loading ...

Overview Company News Filings

Telix Issues New Unquoted Share Rights Under Employee Incentive Scheme

Analysts Offer Insights on Healthcare Companies: AbCellera Biologics (ABCL), Telix Pharmaceuticals (OtherTLPPF) and Johnson & Johnson (JNJ)

Telix Pharmaceuticals Doses First Patient in Phase 3 Brain Cancer Trial

MT Newswires Live

Telix Pharmaceuticals Files Appendix 3B for Proposed Securities Issue

Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma

Top Premarket Decliners

MT Newswires Live

Telix Refinances Convertible Bonds

Telix Showcases Glioblastoma Case Response and Details Offshore Convertible Bond Offer

Telix Raises US$550m in Convertible Note Refi to Extend Debt Maturity

Telix Pharmaceuticals Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Telix and Regeneron Strike Global Radiopharma Alliance in Precision Oncology Push

Telix and Regeneron Announce Strategic Radiopharma Collaboration

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Amid Lingering Geopolitical Uncertainty, CPI Focus

MT Newswires Live

Top Premarket Gainers

MT Newswires Live

Citi Group Entities Drop Below Substantial Holder Threshold in Telix Pharmaceuticals

Telix Pharmaceuticals Says US FDA Accepts New Drug Application for Brain Cancer Imaging Agent

MT Newswires Live

FDA Accepts NDA for TLX101-Px (Pixclara®)

FDA Accepts NDA for TLX101-Px (Pixclara®)

Telix Issues 10,000 New Shares Following Conversion of Unquoted Securities

Telix Seeks ASX Quotation for Additional Ordinary Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/TLX/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TLX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLX\",,,,,undefined,":{"symbol":"TLX","market":"US","secType":"STK","nameCN":"Telix Pharmaceuticals Ltd. (Uplisting)","latestPrice":10.55,"timestamp":1790971200000,"preClose":10.72,"halted":0,"volume":299612,"hourTrading":{"tag":"盘后","latestPrice":10.8414,"preClose":10.55,"latestTime":"19:30 EDT","volume":878,"amount":9299.2913,"timestamp":1790983803330,"change":0.2914,"changeRate":0.027621,"amplitude":0.027621},"delay":0,"changeRate":-0.015858208955223874,"floatShares":272000000,"shares":339000000,"eps":0.095386,"marketStatus":"Market Closed","change":-0.17,"latestTime":"10-02 16:00:00 EDT","open":10.64,"high":10.64,"low":10.45,"amount":3156590.6891400004,"amplitude":0.017724,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.095386,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":1,"listingDate":1718337600000,"exchange":"NASDAQ","adjPreClose":10.72,"preHourTrading":{"tag":"盘前","latestPrice":10.65,"preClose":10.72,"latestTime":"09:29 EDT","volume":3015,"amount":32061.422565,"timestamp":1790947799992,"change":-0.07,"changeRate":-0.00653,"amplitude":0.015681},"postHourTrading":{"tag":"盘后","latestPrice":10.8414,"preClose":10.55,"latestTime":"19:30 EDT","volume":878,"amount":9299.2913,"timestamp":1790983803330,"change":0.2914,"changeRate":0.027621,"amplitude":0.027621},"volumeRatio":0.6704046118825845},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLX\",,,,,undefined,":{"symbol":"TLX","floatShares":272000000,"roa":"2.71%","roe":"7.36%","lyrEps":-0.0211,"volumeRatio":0.6704046118825845,"shares":339000000,"dividePrice":0,"high":10.64,"amplitude":0.017724,"preClose":10.72,"low":10.45,"week52Low":6.28,"pbRate":"7.33","psRate":"4.01","week52High":13.1098,"institutionHeld":0,"latestPrice":10.55,"eps":0.095386,"divideRate":0,"volume":299612,"delay":0,"ttmEps":0.095386,"open":10.64,"prevYearClose":7.49,"prevWeekClose":11.45,"prevMonthClose":10.97,"prevQuarterClose":10.97,"fiveDayClose":11.45,"twentyDayClose":11.74,"sixtyDayClose":11.78},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-19","symbol":"TLX","fiscalQuarterEnding":"2025/12","expectedEps":0.04,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771477200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-08-20","symbol":"TLX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755662400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-02-20","symbol":"TLX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1740027600000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TLX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":5,"updateTime":1758254400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TLX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TLX","date":"2026-10-02","current":110.603233,"percent":0.26383,"low":-584.49693,"twenty":-432.365699,"median":169.774316,"eighty":242.047247,"high":383.853933,"avg":27.808329,"sd":305.705875,"marketCap":3565782844.39},"quantilePoints":[{"date":"2024-11-15","current":155.824924,"twenty":155.852142,"median":155.89297,"eighty":156.178762,"marketCap":4970652360.72},{"date":"2024-11-22","current":153.647458,"twenty":154.191824,"median":155.858947,"eighty":156.314854,"marketCap":4920980791.17},{"date":"2024-11-29","current":168.345354,"twenty":154.8995,"median":156.063085,"eighty":158.49232,"marketCap":5381208976.41},{"date":"2024-12-06","current":169.502133,"twenty":155.171684,"median":156.641474,"eighty":168.045953,"marketCap":5368295184.8},{"date":"2024-12-13","current":166.916392,"twenty":155.838533,"median":162.3233,"eighty":168.045953,"marketCap":5240175366.69},{"date":"2024-12-20","current":168.345354,"twenty":155.961016,"median":166.508117,"eighty":168.916939,"marketCap":5183140063.85},{"date":"2024-12-27","current":169.774316,"twenty":156.233199,"median":167.052484,"eighty":169.706271,"marketCap":5196235069.7},{"date":"2025-01-03","current":162.241165,"twenty":156.342072,"median":167.052484,"eighty":169.542961,"marketCap":4949346723.31},{"date":"2025-01-10","current":163.261978,"twenty":156.5326,"median":167.392713,"eighty":169.228803,"marketCap":4970930045.19},{"date":"2025-01-17","current":180.956065,"twenty":158.029608,"median":167.50507,"eighty":169.864326,"marketCap":5535715919.89},{"date":"2025-01-24","current":187.353158,"twenty":159.608271,"median":167.889662,"eighty":170.577257,"marketCap":5785750657.37},{"date":"2025-01-31","current":199.670965,"twenty":161.249345,"median":168.229933,"eighty":175.407845,"marketCap":6122321793.53},{"date":"2025-02-07","current":198.349538,"twenty":162.241165,"median":168.549491,"eighty":182.861582,"marketCap":6131109878.71},{"date":"2025-02-14","current":185.473256,"twenty":162.64949,"median":169.046583,"eighty":187.353158,"marketCap":5747906307.1},{"date":"2025-02-21","current":203.261161,"twenty":163.302811,"median":169.706271,"eighty":187.353158,"marketCap":6486347833.54},{"date":"2025-02-28","current":187.883767,"twenty":163.584606,"median":170.12499,"eighty":192.087093,"marketCap":5864055113.17},{"date":"2025-03-07","current":182.602424,"twenty":164.112905,"median":170.795004,"eighty":190.960114,"marketCap":5800401146.04},{"date":"2025-03-14","current":179.829719,"twenty":164.766144,"median":174.911776,"eighty":189.692293,"marketCap":5647282174.13},{"date":"2025-03-21","current":184.714961,"twenty":166.589772,"median":175.670662,"eighty":188.147066,"marketCap":5803981960.09},{"date":"2025-03-28","current":187.327482,"twenty":166.94361,"median":178.971501,"eighty":190.960114,"marketCap":5900183330.18},{"date":"2025-04-04","current":159.860903,"twenty":166.94361,"median":178.262158,"eighty":189.692293,"marketCap":5073492527.81},{"date":"2025-04-11","current":177.179731,"twenty":166.589772,"median":177.679515,"eighty":188.147066,"marketCap":5496976372.28},{"date":"2025-04-17","current":173.797147,"twenty":166.916392,"median":177.619467,"eighty":187.883767,"marketCap":5535140863.85},{"date":"2025-04-25","current":193.309359,"twenty":167.052484,"median":178.059203,"eighty":190.062144,"marketCap":6172717887.8},{"date":"2025-05-02","current":198.453445,"twenty":167.392713,"median":178.295984,"eighty":190.062144,"marketCap":6327668326.52},{"date":"2025-05-09","current":181.396737,"twenty":167.481337,"median":179.235568,"eighty":190.062144,"marketCap":5809793224.05},{"date":"2025-05-16","current":176.029393,"twenty":167.481337,"median":178.295984,"eighty":189.78972,"marketCap":5619140101.04},{"date":"2025-05-23","current":172.647682,"twenty":167.528804,"median":178.059203,"eighty":189.451294,"marketCap":5528513460.13},{"date":"2025-05-30","current":176.779306,"twenty":167.780801,"median":177.456621,"eighty":188.460572,"marketCap":5687082652.57},{"date":"2025-06-06","current":173.121803,"twenty":167.88049,"median":177.318176,"eighty":187.949592,"marketCap":5638091901.1},{"date":"2025-06-13","current":167.838743,"twenty":167.88049,"median":176.508379,"eighty":187.45928,"marketCap":5463186103.94},{"date":"2025-06-20","current":168.923551,"twenty":167.889662,"median":176.029393,"eighty":187.353158,"marketCap":5442074695.06},{"date":"2025-06-27","current":165.669807,"twenty":167.592888,"median":175.625224,"eighty":187.337752,"marketCap":5412704421.76},{"date":"2025-07-03","current":162.348276,"twenty":167.428163,"median":175.082406,"eighty":187.024133,"marketCap":5325445922.59},{"date":"2025-07-11","current":163.297285,"twenty":166.671427,"median":174.480785,"eighty":186.439488,"marketCap":5350247552.51},{"date":"2025-07-18","current":171.228286,"twenty":165.90028,"median":173.909122,"eighty":186.045921,"marketCap":5541358073.91},{"date":"2025-07-25","current":144.045965,"twenty":165.670181,"median":173.731386,"eighty":185.637634,"marketCap":4750367012.62},{"date":"2025-08-01","current":136.589468,"twenty":164.955304,"median":173.25664,"eighty":185.381192,"marketCap":4384547406.6},{"date":"2025-08-08","current":119.575098,"twenty":163.364827,"median":173.121803,"eighty":185.031841,"marketCap":3879545892.37},{"date":"2025-08-15","current":118.626089,"twenty":162.985468,"median":172.816584,"eighty":184.520886,"marketCap":3844757658.1},{"date":"2025-08-22","current":367.342977,"twenty":162.565192,"median":172.783145,"eighty":185.031841,"marketCap":3983594342.69},{"date":"2025-08-29","current":297.28853,"twenty":162.917681,"median":173.086118,"eighty":186.439488,"marketCap":3223899680.91},{"date":"2025-09-05","current":280.194275,"twenty":162.97191,"median":173.155042,"eighty":187.353158,"marketCap":3038523660.62},{"date":"2025-09-12","current":284.24913,"twenty":163.053254,"median":173.392729,"eighty":189.722035,"marketCap":3082495919.22},{"date":"2025-09-19","current":299.993591,"twenty":163.181765,"median":173.840405,"eighty":192.411646,"marketCap":3253234303.96},{"date":"2025-09-26","current":303.368871,"twenty":163.269039,"median":174.34097,"eighty":195.332201,"marketCap":3289837005.56},{"date":"2025-10-03","current":316.222238,"twenty":163.331056,"median":174.844246,"eighty":197.182743,"marketCap":3429223360.77},{"date":"2025-10-10","current":308.943311,"twenty":163.584606,"median":175.579785,"eighty":198.432664,"marketCap":3350288154.24},{"date":"2025-10-17","current":337.724829,"twenty":164.112905,"median":175.99796,"eighty":200.117317,"marketCap":3662404902.51},{"date":"2025-10-24","current":335.676999,"twenty":164.422238,"median":176.508379,"eighty":204.373856,"marketCap":3640197520.67},{"date":"2025-10-31","current":328.898919,"twenty":164.871944,"median":177.318176,"eighty":280.077091,"marketCap":3566693671.28},{"date":"2025-11-07","current":302.845362,"twenty":165.230483,"median":178.059203,"eighty":285.744085,"marketCap":3284159889.46},{"date":"2025-11-14","current":289.051675,"twenty":165.371547,"median":178.295984,"eighty":290.299055,"marketCap":3134576370.19},{"date":"2025-11-21","current":278.19044,"twenty":165.561349,"median":179.014446,"eighty":289.541689,"marketCap":3016793389.39},{"date":"2025-11-28","current":310.533522,"twenty":165.669807,"median":179.412236,"eighty":291.060611,"marketCap":3367532955.32},{"date":"2025-12-05","current":306.208941,"twenty":165.670741,"median":180.00406,"eighty":294.691227,"marketCap":3320635708.33},{"date":"2025-12-12","current":286.055209,"twenty":165.873166,"median":180.584513,"eighty":295.905706,"marketCap":3102081667.78},{"date":"2025-12-19","current":244.707348,"twenty":165.940952,"median":181.091444,"eighty":294.691227,"marketCap":2653691145.03},{"date":"2025-12-26","current":248.848958,"twenty":166.394684,"median":181.60348,"eighty":294.390689,"marketCap":2698604201.29},{"date":"2026-01-02","current":236.757004,"twenty":166.574536,"median":182.507221,"eighty":293.840477,"marketCap":2567474872.89},{"date":"2026-01-09","current":234.880062,"twenty":166.797362,"median":182.734458,"eighty":292.111558,"marketCap":2547120662.92},{"date":"2026-01-16","current":240.619616,"twenty":166.998047,"median":183.212494,"eighty":291.104403,"marketCap":2609362374.53},{"date":"2026-01-23","current":233.793317,"twenty":167.188576,"median":183.578507,"eighty":290.823686,"marketCap":2535335622.99},{"date":"2026-01-30","current":230.611959,"twenty":167.428163,"median":183.988776,"eighty":290.419247,"marketCap":2500835870.83},{"date":"2026-02-06","current":214.320895,"twenty":167.500324,"median":184.979028,"eighty":290.056234,"marketCap":2324169939.4},{"date":"2026-02-13","current":194.105832,"twenty":167.571527,"median":185.74722,"eighty":289.461299,"marketCap":2104950801.53},{"date":"2026-02-20","current":-349.931165,"twenty":167.550165,"median":186.245055,"eighty":289.186438,"marketCap":2493259551.93},{"date":"2026-02-27","current":-337.576812,"twenty":166.94361,"median":185.358176,"eighty":288.884688,"marketCap":2405234781.68},{"date":"2026-03-06","current":-357.014534,"twenty":165.886723,"median":184.229774,"eighty":287.796958,"marketCap":2543728559.75},{"date":"2026-03-13","current":-380.87359,"twenty":165.371547,"median":183.661424,"eighty":286.105301,"marketCap":2713724328.68},{"date":"2026-03-20","current":-427.441295,"twenty":164.112905,"median":183.427298,"eighty":285.888656,"marketCap":3045519229.47},{"date":"2026-03-27","current":-448.04178,"twenty":163.181765,"median":182.800475,"eighty":285.212188,"marketCap":3192297684.03},{"date":"2026-04-02","current":-425.435204,"twenty":162.890567,"median":182.629922,"eighty":285.17117,"marketCap":3031225831.43},{"date":"2026-04-10","current":-492.382264,"twenty":161.467054,"median":181.810223,"eighty":284.24913,"marketCap":3508223631.57},{"date":"2026-04-17","current":-499.465833,"twenty":158.955031,"median":181.091444,"eighty":284.07528,"marketCap":3558694058.36},{"date":"2026-04-24","current":-507.89561,"twenty":156.233199,"median":180.584513,"eighty":282.031139,"marketCap":3618756217.23},{"date":"2026-05-01","current":-532.518745,"twenty":154.872282,"median":180.00406,"eighty":281.147736,"marketCap":3794196059.21},{"date":"2026-05-08","current":-508.824558,"twenty":144.045965,"median":179.412236,"eighty":280.966174,"marketCap":3625374971.37},{"date":"2026-05-15","current":-506.065728,"twenty":140.182144,"median":178.86094,"eighty":280.209239,"marketCap":3605718311.9},{"date":"2026-05-22","current":-452.537308,"twenty":125.947014,"median":178.262158,"eighty":280.194275,"marketCap":3224328322.29},{"date":"2026-05-29","current":-444.681415,"twenty":120.122064,"median":178.059203,"eighty":279.725537,"marketCap":3168355079.47},{"date":"2026-06-05","current":-452.683664,"twenty":115.968865,"median":177.318176,"eighty":279.589795,"marketCap":3225371110.32},{"date":"2026-06-12","current":-453.131496,"twenty":29.784924,"median":176.508379,"eighty":278.469383,"marketCap":3228561906.13},{"date":"2026-06-18","current":-479.232706,"twenty":-319.885885,"median":176.029393,"eighty":275.361846,"marketCap":3414533028.17},{"date":"2026-06-26","current":-505.22407,"twenty":-336.088027,"median":175.625224,"eighty":265.637187,"marketCap":3599721496.58},{"date":"2026-07-02","current":-567.292731,"twenty":-347.690038,"median":175.082406,"eighty":259.576863,"marketCap":4041960704.33},{"date":"2026-07-10","current":-538.02731,"twenty":-371.335373,"median":174.480785,"eighty":256.751103,"marketCap":3833444584.84},{"date":"2026-07-17","current":-497.824928,"twenty":-406.861587,"median":173.909122,"eighty":252.484997,"marketCap":3547002606.6},{"date":"2026-07-24","current":-487.362208,"twenty":-419.925535,"median":173.731386,"eighty":249.449835,"marketCap":3472455733.71},{"date":"2026-07-31","current":-475.018244,"twenty":-425.317007,"median":173.324997,"eighty":249.116107,"marketCap":3384504988.78},{"date":"2026-08-07","current":-543.110083,"twenty":-431.380818,"median":173.121803,"eighty":248.587668,"marketCap":3869659340.88},{"date":"2026-08-14","current":-563.285348,"twenty":-444.416873,"median":172.850024,"eighty":247.242146,"marketCap":4013408103.64},{"date":"2026-08-21","current":112.812357,"twenty":-445.662886,"median":172.57995,"eighty":245.774025,"marketCap":3778875522.96},{"date":"2026-08-28","current":114.191675,"twenty":-444.681415,"median":171.69944,"eighty":244.665977,"marketCap":3825078550.57},{"date":"2026-09-04","current":120.218119,"twenty":-444.416873,"median":171.125205,"eighty":244.246526,"marketCap":4026946335.18},{"date":"2026-09-11","current":113.993217,"twenty":-443.358706,"median":170.839525,"eighty":243.230652,"marketCap":3818430784.57},{"date":"2026-09-18","current":128.771395,"twenty":-438.399131,"median":170.279278,"eighty":242.301839,"marketCap":4313455406.44},{"date":"2026-09-25","current":113.11909,"twenty":-435.525335,"median":170.22876,"eighty":242.197204,"marketCap":3789150143.08},{"date":"2026-10-02","current":106.450812,"twenty":-432.365699,"median":169.774316,"eighty":242.047247,"marketCap":3565782844.39}],"updateTime":1791116422610},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627073260","title":"Telix Issues New Unquoted Share Rights Under Employee Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2627073260","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627073260?lang=en_us&edition=fundamental","pubTime":"2026-04-16 16:13","pubTimestamp":1776327200,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has notified the market of the issue of new unquoted share...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-issues-new-unquoted-share-rights-under-employee-incentive-scheme?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-issues-new-unquoted-share-rights-under-employee-incentive-scheme?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627284519","title":"Analysts Offer Insights on Healthcare Companies: AbCellera Biologics (ABCL), Telix Pharmaceuticals (OtherTLPPF) and Johnson & Johnson (JNJ)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627284519","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627284519?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:21","pubTimestamp":1776255689,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AbCellera Biologics (ABCL), Telix Pharmaceuticals (T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abcellera-biologics-abcl-telix-pharmaceuticals-othertlppf-and-johnson-johnson-jnj-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abcellera-biologics-abcl-telix-pharmaceuticals-othertlppf-and-johnson-johnson-jnj-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1221951046.USD","LU0426412945.USD","IE00BJJMRZ35.SGD","LU1057294990.SGD","JNJ","LU1043141396.HKD","LU0683600562.USD","LABU","XLV","LU2592432038.USD","SG9999002224.SGD","SGXZ57979304.SGD","BK4559","TLX","IE00BFXG1179.USD","LU1267930813.SGD","LU1261432733.SGD","LU2129689514.USD","XBI","LU2347655156.SGD","IE00BJT1NW94.SGD","HCSG","LU1066051498.USD","ABCL","LU2468319806.SGD","LU0889566641.SGD","IE000SO60NU8.SGD","IE00BLSP4452.SGD","LU0345769631.USD","LU0098860793.USD","LU1935042991.SGD","LU0234570918.USD","LU1718418525.SGD","LU0203345920.USD","LU0432979614.USD","LU0029874061.USD","LU2505996681.GBP","IE00B4R5TH58.HKD","BK4568","IE000F7OJYX1.SGD","LU1244550221.USD","LU1244550494.USD","LU2471134952.CNY","LU1061106388.HKD","BK4139","IE00B19Z3581.USD","IE000BZT7R73.USD","IE00BFTCPJ56.SGD","BK4533","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627400631","title":"Telix Pharmaceuticals Doses First Patient in Phase 3 Brain Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2627400631","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627400631?lang=en_us&edition=fundamental","pubTime":"2026-04-15 17:30","pubTimestamp":1776245418,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals (TLX) said Wednesday it dosed the initial patient in a Phase 3 clinical trial evaluating its radiopharmaceutical therapy for recurrent glioblastoma, a type of brain cancer.The gl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","TLX","BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627478475","title":"Telix Pharmaceuticals Files Appendix 3B for Proposed Securities Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2627478475","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627478475?lang=en_us&edition=fundamental","pubTime":"2026-04-15 07:48","pubTimestamp":1776210514,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals ( ($AU:TLX) ) has shared an update. Telix Pharmaceuticals has lodged an Appendix 3B with the ASX outlining a proposed issue o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-files-appendix-3b-for-proposed-securities-issue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-files-appendix-3b-for-proposed-securities-issue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627203064","title":"Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2627203064","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627203064?lang=en_us&edition=fundamental","pubTime":"2026-04-15 06:50","pubTimestamp":1776207000,"startTime":"0","endTime":"0","summary":"The patient was dosed at Austin Health in Melbourne, Australia, under the supervision of Professor Hui Gan. IPAX BrIGHTis assessing the safety and efficacy of TLX101-Tx in combination with chemotherapy , compared to chemotherapy alone. The global, multicenter, open-label study will enroll patients with radiographically confirmed recurrent glioblastoma at first recurrence.IPAX BrIGHT expands upon promising data from earlier trials in the recurrent glioblastoma setting, includingIPAX-1[3], which reported a median overall survival  of 13 months from the initiation of treatment with TLX101-Tx, or 23 months from initial diagnosis[4]. Preliminary results from the IPAX-Linz investigator-initiated trial of TLX101-Tx were consistent and confirmatory to IPAX-1, with a median OS of12.4 monthsfrom initiation of treatment and32.2 monthsfrom initial diagnosis[5]. Beyond the clinical trial setting, an early access program for TLX101-Tx in Europe has dosed 18 patients at first recurrence or later, fur","market":"hk","thumbnail":"https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/telix-doses-first-patient-in-phase-3-ipax-bright-trial-of-tlx101-tx-for-recurrent-glioblastoma-302742412.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASX.AU","XAO.AU","GBM.AU","ASX","XKO.AU","BK7067","BK4543","XJO.AU","BK4141","SEC.AU","BK4526","BK7039","BK7104","TLX","TLX.AU","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627445663","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2627445663","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627445663?lang=en_us&edition=fundamental","pubTime":"2026-04-14 20:01","pubTimestamp":1776168074,"startTime":"0","endTime":"0","summary":"T1 Energy  shares were 5.7% lower in Tuesday's premarket activity after the company said it is proposing an underwritten public offering of $125 million in convertible senior notes due 2031.CarMax  shares were down 4.2% after the company reported lower fiscal Q4 adjusted earnings and net sales and operating revenue from a year earlier.Telix Pharmaceuticals  stock was 5.1% lower after the company said it commenced a $550 million offering of convertible notes due 2031.Wells Fargo  shares were down 2.4% after the Wall Street bank reported lower-than-expected Q1 revenue.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1894683348.USD","LU0048573561.USD","LU0251131958.USD","LU0942090050.USD","LU1074936037.SGD","KMX","LU1267930573.SGD","LU0175139822.USD","LU2236285917.USD","LU0787776722.HKD","LU0211327993.USD","BK4207","LU1069347547.HKD","LU1506573853.SGD","LU0314106906.USD","IE00B7SZLL34.SGD","LU0130102774.USD","LU1814569148.SGD","LU0154236417.USD","LU0640476718.USD","BK4559","BK4585","LU0029864427.USD","LU0149725797.USD","LU0683600562.USD","LU1668664300.SGD","LU1267930227.SGD","LU2361044865.SGD","LU0310799852.SGD","LU0477156953.USD","LU0106831901.USD","LU1035773651.USD","BK4588","TLX","LU0208291251.USD","IE000M9KFDE8.USD","TE","LU0251142724.SGD","BK4139","BK4504","IE0002270589.USD","LU1791807156.HKD","LU1363072403.SGD","TLX.AU","BK4096","LU0971096721.USD","LU0310800379.SGD","LU2361045086.USD","LU0417517546.SGD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627416002","title":"Telix Refinances Convertible Bonds","url":"https://stock-news.laohu8.com/highlight/detail?id=2627416002","media":"prnewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627416002?lang=en_us&edition=fundamental","pubTime":"2026-04-14 16:32","pubTimestamp":1776155520,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia and INDIANAPOLIS, Ind., April 14, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited   today launches an offering of US$550 million convertible notes due 2031 to be issued by its wholly-owned subsidiary, Telix Pharmaceuticals  Inc. , and guaranteed by Telix and Telix Pharmaceuticals  Inc. . The convertible notes, also referred to as \"convertible bonds\" , are convertible into fully paid ordinary shares in Telix .Managing Director and Group CEO, Dr. Christian Behrenbruch, said: \"The refinance of the existing Convertible Bonds represents our proactive approach to capital management. The new Convertible Bonds will continue to provide the business with cost effective financing.\". The new Convertible Bonds represent attractive, low-cost financing to Telix and are non-dilutive until any potential future conversions occur. The initial conversion price will be at a premium to Telix's current share price.After deduction of commissions, professional fees and other administrat","market":"fut","thumbnail":"https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/telix-refinances-convertible-bonds-302741509.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4543","TLX","SEC.AU","BK7039","BK4141","BK7067","TLX.AU","ASX.AU","ASX","BK4526","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627619415","title":"Telix Showcases Glioblastoma Case Response and Details Offshore Convertible Bond Offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2627619415","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627619415?lang=en_us&edition=fundamental","pubTime":"2026-04-14 15:53","pubTimestamp":1776153223,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals ( ($AU:TLX) ) just unveiled an update. Telix Pharmaceuticals has highlighted clinical imaging data showing a patient with rec...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-showcases-glioblastoma-case-response-and-details-offshore-convertible-bond-offer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-showcases-glioblastoma-case-response-and-details-offshore-convertible-bond-offer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["US10Y.BOND","TMF","US7Y.BOND","TLTW","BK4139","US3Y.BOND","US12M.BOND","US6M.BOND","TLT","US5Y.BOND","US30Y.BOND","US2Y.BOND","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627418997","title":"Telix Raises US$550m in Convertible Note Refi to Extend Debt Maturity","url":"https://stock-news.laohu8.com/highlight/detail?id=2627418997","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627418997?lang=en_us&edition=fundamental","pubTime":"2026-04-14 15:11","pubTimestamp":1776150670,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has launched a US$550 million offering of five‑year ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-raises-us550m-in-convertible-note-refi-to-extend-debt-maturity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-raises-us550m-in-convertible-note-refi-to-extend-debt-maturity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627432787","title":"Telix Pharmaceuticals Price Target Maintained With a $20.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2627432787","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627432787?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:12","pubTimestamp":1776078720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TLX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 13, 2026 07:12 ET (11:12 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627101146","title":"Telix and Regeneron Strike Global Radiopharma Alliance in Precision Oncology Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2627101146","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627101146?lang=en_us&edition=fundamental","pubTime":"2026-04-13 06:59","pubTimestamp":1776034766,"startTime":"0","endTime":"0","summary":"An announcement from Telix Pharmaceuticals ( ($AU:TLX) ) is now available. Telix Pharmaceuticals and Regeneron Pharmaceuticals have entered a strat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-and-regeneron-strike-global-radiopharma-alliance-in-precision-oncology-push?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-and-regeneron-strike-global-radiopharma-alliance-in-precision-oncology-push?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627101920","title":"Telix and Regeneron Announce Strategic Radiopharma Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2627101920","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627101920?lang=en_us&edition=fundamental","pubTime":"2026-04-13 06:57","pubTimestamp":1776034620,"startTime":"0","endTime":"0","summary":"Telix to receive US$40 million upfront for four initial programs with optionality on a per program basis to co-fund commercialization and profit-share or earnup to an aggregate of US$2.1 billion in developmentand commercial milestone payments pluslow double-digit royalties.","market":"other","thumbnail":"https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/telix-and-regeneron-announce-strategic-radiopharma-collaboration-302739967.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","BK4585","LU0289739699.SGD","LU2362540622.SGD","LU2362541513.USD","LU0109394709.USD","LU0889565916.HKD","LU2237438978.USD","LU0823416689.USD","LU2468319806.SGD","BK4588","BK7067","TLX","LU2362541273.HKD","ASX.AU","LU2023250504.SGD","LU0823434583.USD","LU1917777945.USD","LU0823434740.USD","LU1974910355.USD","LU0053666078.USD","LU2106854487.HKD","LU0058720904.USD","REGN","BK7039","ASX","BK4139","TLX.AU","LU0882574055.USD","SEC.AU","BK4141","BK4526","BK4543","LU2089984988.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626118762","title":"Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Amid Lingering Geopolitical Uncertainty, CPI Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2626118762","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626118762?lang=en_us&edition=fundamental","pubTime":"2026-04-10 21:15","pubTimestamp":1775826917,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.1% and the actively traded Invesco QQQ Trust (QQQ) was 0.1% higher in Friday's premarket activity amid lingering geopolitica","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["UNG","VHT","XSD","BITO","EQR","EETH","IYH","QQQ","NMG.AU","FAZ","EXI","SLM.AU","VIS","AOS","FAS","SLM","IYE","USO","SHAK","GLD","SLV","XLE","IGM","XLF","XLI","XLK","RTH","VDC","NMG","IBB","IVV","IYJ","SPY.AU","SOXX","TSM","XLV","E","RTH.AU","TLX.AU","BETH","IYK","FDN","EEM","XLY","VHT.AU","IYW","TLX","XLP","XRT","SPY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626019478","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2626019478","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626019478?lang=en_us&edition=fundamental","pubTime":"2026-04-10 19:26","pubTimestamp":1775820373,"startTime":"0","endTime":"0","summary":"Xiao-I  shares were over 70% higher in Friday premarket activity, erasing the prior session's loss.Wellgistics Health  shares were up 31% after the company said overnight it terminated its settlement agreement with Silverback Capital and will no longer issue any additional shares to Silverback.Lotus Technology  stock was 11% higher after the company reported a narrower Q4 net loss from a year earlier.Telix Pharmaceuticals  shares were up nearly 9%, a day after the company said the US Food and Drug Administration accepted its resubmitted new drug application for its investigational glioma imaging agent Pixclara.Taiwan Semiconductor Manufacturing  stock was up 2.3% after the company reported higher Q1 net revenue.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFXG0V08.USD","TSMG","LU1852331112.SGD","LU1934455194.USD","SG9999004220.SGD","LU0359201885.HKD","BK4503","LU0541502299.USD","BK4581","LU2106854487.HKD","LU0359201612.USD","LU0541501648.USD","LU0238689110.USD","LU0861579265.USD","LU1989772840.SGD","TSMZ","LU2271345857.HKD","LU1989764664.SGD","LU2294711713.HKD","LU1282649810.SGD","BK4612","LU2063271972.USD","LU0359202008.SGD","LU2543165471.USD","LU0823414551.USD","LU0965509010.AUD","BK4550","LU0264606111.USD","LU0488056044.USD","LU1508157978.USD","IE00B5TLWC47.USD","AIXI","LU0965509101.SGD","BK4099","LU2360108059.USD","LU0823421333.USD","BK4527","IE0004091025.USD","IE00B3M56506.USD","LU0143863198.USD","LU0719512351.SGD","LU1712237335.SGD","BK4602","LU0289960550.SGD","BK4548","BK4554","LU2860962120.EUR","LU0572939691.SGD","SGXZ51526630.SGD","LU2491050154.USD","TLX","BK4532","LU0345770993.USD","LU0345770308.USD","SGXZ81514606.USD","BK4023","LU1316542783.SGD","IE00BHPRN162.USD","LU0175139822.USD","LU1934455277.USD","03145","LU2111349929.HKD","LU0792757196.USD","TSMY","LU0124676726.USD","IE00BD6J9T35.USD","BK4591","LU2023250504.SGD","STSM","LU1211504680.USD","LU2089283258.USD","LU2023251221.USD","BK4533","WGRX","LU0348723411.USD","LU1323610961.USD","IE00BQXX3F31.USD","LU2491050071.SGD","BK4588","BK7083","LU2028103732.USD","LU2357125470.USD","SGXZ99366536.SGD","LU0823414478.USD","LU1282649067.USD","LU0158827948.USD","LU0082616367.USD","LU2211814178.USD","LU0094547139.USD","LOT","LU2125154778.USD","LU1037948541.HKD","LU0889566641.SGD","LU0198837287.USD","LU0642271901.SGD","LU1023057109.AUD","LU2054465674.USD","BK4141","LU0965509283.SGD","LU2041044095.USD","LU2298321311.HKD","LU1868837722.USD","LU0384037296.USD","LU0823421416.USD","LU1989764748.USD","LU2237443622.USD","BK4175","LU2211815571.USD","LU1623119135.USD","LU2089284900.SGD","LU0353189763.USD","LU0965508806.USD","LU0889565833.HKD","IE00BQXX3C00.GBP","IE0004086264.USD","IE00BZ199S13.USD","LU0572940350.SGD","LU0316494557.USD","LU0143863784.USD","IE00BKPKM429.USD","LU2360106780.USD","BK4534","LU0109392836.USD","BK4139","LU2250418816.HKD","IE0004445239.USD","BK4526","BK4512","LU2471134879.HKD","LU1934455863.HKD","LU2458330169.SGD","LU2471134952.CNY","LU2506951792.HKD","LU1989772923.USD","LU2237443549.SGD","LU1803068979.SGD","LU1917777945.USD","LU0056508442.USD","LU1974910355.USD","LU2247934214.USD","LU2092937221.SGD","LU2249611893.SGD","LU2491049909.HKD","LU2663582299.SGD","TSMX","IE00BQXX3D17.EUR","LU0323591593.USD","LU1037948897.HKD","LU2087625088.SGD","LU2125154935.USD","LU2471134796.USD","BK4605","BK4585","BK4505","IE00BYQQ9H92.USD","BK4543","LU0689626769.HKD","TSMU","LU2750360641.GBP","BK7067","LU0158827781.USD","LU1868838027.USD","LU2458330243.SGD","LU0878004406.USD","LU0882747503.HKD","LU1868837565.USD","LU2237443382.USD","LU2471134523.USD","LU0353189680.USD","LU0878005551.USD","TSM","LU2360032135.SGD","LU2750360997.AUD","LU2133065610.SGD","LU2237443978.SGD","SG9999000418.SGD","LU1267930813.SGD","BK7095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626316298","title":"Citi Group Entities Drop Below Substantial Holder Threshold in Telix Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2626316298","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626316298?lang=en_us&edition=fundamental","pubTime":"2026-04-10 15:17","pubTimestamp":1775805452,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Citigroup Global Markets Australia and related Citi group entities have notified...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/citi-group-entities-drop-below-substantial-holder-threshold-in-telix-pharmaceuticals?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/citi-group-entities-drop-below-substantial-holder-threshold-in-telix-pharmaceuticals?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1244550577.SGD","LU0130102774.USD","BK4534","BK4207","LU0310800965.SGD","LU2125154935.USD","LU0052756011.USD","BK4139","TLX","BK4504","LU2236285917.USD","BK4585","BK4559","LU1201861249.SGD","LU0128525689.USD","LU1668664300.SGD","LU0130517989.USD","BK4588","LU1366192091.USD","LU0980610538.SGD","LU1791807156.HKD","LU2456880835.USD","LU0320765646.SGD","LU2462157665.USD","LU0162691827.USD","LU2125154778.USD","LU2417539215.USD","LU0106831901.USD","LU1244550494.USD","LU0170899867.USD","LU1244550221.USD","BK4566","LU1267930227.SGD","LU1162221912.USD","LU0648001328.SGD","LU2360032135.SGD","LU0098860793.USD","LU0477156953.USD","IE00BSNM7G36.USD","LU1506573853.SGD","LU0072461881.USD","LU0314106906.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626126156","title":"Telix Pharmaceuticals Says US FDA Accepts New Drug Application for Brain Cancer Imaging Agent","url":"https://stock-news.laohu8.com/highlight/detail?id=2626126156","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626126156?lang=en_us&edition=fundamental","pubTime":"2026-04-10 07:25","pubTimestamp":1775777139,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  said the US Food and Drug Administration  has accepted its resubmitted new drug application for TLX101-Px, an investigational positron emission tomography  agent for the imaging of glioma, a form of brain cancer, according to a Friday filing with the Australian bourse.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PET.AU","BK4588","LABU","BK4139","TLX","TLX.AU","BK7067","BK4585","BK7047"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626819156","title":"FDA Accepts NDA for TLX101-Px (Pixclara®)","url":"https://stock-news.laohu8.com/highlight/detail?id=2626819156","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626819156?lang=en_us&edition=fundamental","pubTime":"2026-04-10 06:51","pubTimestamp":1775775060,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia and INDIANAPOLIS, April  10, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the United States (U.S.) Food and Drug Ad","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/09/3271481/0/en/FDA-Accepts-NDA-for-TLX101-Px-Pixclara.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4141","BK4588","LABU","ASX","BK4135","TLX","BK4139","BK4585","BK4526","CNS","BK4543"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626156814","title":"FDA Accepts NDA for TLX101-Px (Pixclara®)","url":"https://stock-news.laohu8.com/highlight/detail?id=2626156814","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626156814?lang=en_us&edition=fundamental","pubTime":"2026-04-10 06:50","pubTimestamp":1775775000,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia and INDIANAPOLIS, April 10, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited  today announces that the United States  Food and Drug Administration  has accepted the Company's resubmitted New Drug Application  for TLX101-Px[1], , an investigational PET[3] agent for the imaging of glioma , and has assigned a PDUFA[4] goal date of September 11, 2026.The approval of TLX101-Px will fulfil a significant unmet medical need for the characterization of recurrent or progressive glioma from treatment related changes in both adult and pediatric patients[5]. Neuroimaging of glioma with 18F-FET is already broadly recommended in international clinical practice guidelines – including NCCN Guidelines[6] – and TLX101-Px has been granted Orphan Drug[7] and Fast Track[8] designations by the FDA.Patrick Wen, MD, E. Antonio Chiocca,MD, PhD, Family Endowed Chair in Neuro-Oncology at Mass General Brigham Cancer Institute, added, \"Distinguishing tumor progression from treatment-related c","market":"fut","thumbnail":"https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/1920208/Telix_Main_Logo_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/fda-accepts-nda-for-tlx101-px-pixclara-302738824.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","LABU","SEC.AU","BK4543","BK4139","BK4585","TLX.AU","BK4588","BK4135","ASX.AU","BK4141","BK7104","CNS","BK7039","GBM.AU","BK4526","ASX","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626976484","title":"Telix Issues 10,000 New Shares Following Conversion of Unquoted Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2626976484","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626976484?lang=en_us&edition=fundamental","pubTime":"2026-04-09 08:37","pubTimestamp":1775695078,"startTime":"0","endTime":"0","summary":"An update from Telix Pharmaceuticals ( ($AU:TLX) ) is now available. Telix Pharmaceuticals has issued 10,000 new fully paid ordinary shares followi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-issues-10000-new-shares-following-conversion-of-unquoted-securities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-issues-10000-new-shares-following-conversion-of-unquoted-securities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626976486","title":"Telix Seeks ASX Quotation for Additional Ordinary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2626976486","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626976486?lang=en_us&edition=fundamental","pubTime":"2026-04-09 08:36","pubTimestamp":1775695009,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals ( ($AU:TLX) ) has issued an announcement. Telix Pharmaceuticals has applied for quotation on the ASX of an additional 222,840...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-seeks-asx-quotation-for-additional-ordinary-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-seeks-asx-quotation-for-additional-ordinary-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TLX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}